An Immunological Study On Rheumatic Carditis

Sahar Sayed Allam El-Sherief;

Abstract


This study was performed in the unit of rheumatic and connective
'
tissue diseases in the department of internal medicine, Assiut university

hospital at the period January 1997: December 1998.

This study included 40 patients with rheumatic fever that were classified into two groups according to treatment; the first group treated with aspirin (group I) and the second group treated with corticosteroids (group II).
Those patients fulfilled the Jones criteria of diagnosis ofRF. Other I 0 patients with valvular heart disease secondary to previous rheumatic activity (group III) and I 0 healthy persons as a control group (group IV) were also included in the study.
The aim of the study was:


- Evaluation of

'
som


e immunological changes that occurs in RF such as


the changes in T helper and T suppressor.cells blood counts and their ratio and serum level of IL-2..
- Study the effect of treatment by corticosteroids and comparing it by that

of spirin in modifying the previously mentioned immunological aspects.


The study reveald that:


- T helper lymphocytes count and serum level of IL•2 increased with disease activity while T suppressor counts decreased and hence increase the T helper/T suppressor ratio.
- At follow up the ratio ofT helper/T supressor and the serum level of

IL-2 decreased to levels statistically insignificant from control.

- There were insignificant differences in the immunological parameters between patients treated with corticosteroids or those treated with aspmn.


Other data

Title An Immunological Study On Rheumatic Carditis
Other Titles دراسة مناعية على مرضى الالتهاب الروماتيزمى بعضلة القلب
Authors Sahar Sayed Allam El-Sherief
Issue Date 1999

Attached Files

File SizeFormat
B15233.pdf1 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.